Comparability of antimullerian hormone levels among commercially available immunoassays.

ABSTRACT:

Objective

To compare antimüllerian hormone (AMH) levels among three commercially available AMH immunoassays: AMH Gen II (Beckman Coulter), Ultrasensitive AMH (Ansh Labs), and picoAMH (Ansh Labs).

Design

Cross-sectional.

Setting

Academic reproductive endocrinology program.

Patient(s)

90 newly diagnosed breast cancer patients before cancer treatment.

Intervention(s)

None.

Main outcome measure(s)

Proportion of detectable AMH levels by immunoassay, and comparability among assays.

Result(s)

At a mean age of 38.1 years, the median (interquartile range) AMH level for the cohort was 0.92 [1.35] ng/mL for the Gen II assay, 1.68 [2.30] ng/mL for the Ultrasensitive assay, and 1.52 [2.41] ng/mL for the picoAMH assay. Significantly higher proportions of

SUBMITTER: Su HI 

PROVIDER: S-EPMC4334563 | biostudies-literature | 2014 Jun

REPOSITORIES: biostudies-literature